These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
427 related articles for article (PubMed ID: 32098634)
1. The duration of chemoprophylaxis against malaria after treatment with artesunate-amodiaquine and artemether-lumefantrine and the effects of pfmdr1 86Y and pfcrt 76T: a meta-analysis of individual patient data. Bretscher MT; Dahal P; Griffin J; Stepniewska K; Bassat Q; Baudin E; D'Alessandro U; Djimde AA; Dorsey G; Espié E; Fofana B; González R; Juma E; Karema C; Lasry E; Lell B; Lima N; Menéndez C; Mombo-Ngoma G; Moreira C; Nikiema F; Ouédraogo JB; Staedke SG; Tinto H; Valea I; Yeka A; Ghani AC; Guerin PJ; Okell LC BMC Med; 2020 Feb; 18(1):47. PubMed ID: 32098634 [TBL] [Abstract][Full Text] [Related]
2. In vivo/ex vivo efficacy of artemether-lumefantrine and artesunate-amodiaquine as first-line treatment for uncomplicated falciparum malaria in children: an open label randomized controlled trial in Burkina Faso. Lingani M; Bonkian LN; Yerbanga I; Kazienga A; Valéa I; Sorgho H; Ouédraogo JB; Mens PF; Schallig HDFH; Ravinetto R; d'Alessandro U; Tinto H Malar J; 2020 Jan; 19(1):8. PubMed ID: 31906948 [TBL] [Abstract][Full Text] [Related]
3. SELECTION OF PFCRT 76T AND PFMDR1 86Y MUTANT PLASMODIUM FALCIPARUM AFTER TREATMENT OF UNCOMPLICATED MALARIA WITH ARTESUNATE-AMODIAQUINE IN REPUBLIC OF GUINEA. Beavogui AH; Diawara EY; Cherif MS; Delamou A; Diallo N; Traore A; Millimouno P; Camara D; Sylla MM; Toure AA; Diallo MS; Toure S; Togo A; Camara G; Kourouma K; Sagara I; Dicko A; Djimde A J Parasitol; 2021 Sep; 107(5):778-782. PubMed ID: 34581793 [TBL] [Abstract][Full Text] [Related]
4. Monitoring of efficacy, tolerability and safety of artemether-lumefantrine and artesunate-amodiaquine for the treatment of uncomplicated Plasmodium falciparum malaria in Lambaréné, Gabon: an open-label clinical trial. Adegbite BR; Edoa JR; Honkpehedji YJ; Zinsou FJ; Dejon-Agobe JC; Mbong-Ngwese M; Lotola-Mougueni F; Koehne E; Lalremruata A; Kreidenweiss A; Nguyen TT; Kun J; Agnandji ST; Lell B; Safiou AR; Obone Atome FA; Mombo-Ngoma G; Ramharter M; Velavan TP; Mordmüller B; Kremsner PG; Adegnika AA Malar J; 2019 Dec; 18(1):424. PubMed ID: 31842893 [TBL] [Abstract][Full Text] [Related]
5. Selection of Plasmodium falciparum pfcrt and pfmdr1 polymorphisms after treatment with artesunate-amodiaquine fixed dose combination or artemether-lumefantrine in Liberia. Otienoburu SD; Maïga-Ascofaré O; Schramm B; Jullien V; Jones JJ; Zolia YM; Houzé P; Ashley EA; Kiechel JR; Guérin PJ; Le Bras J; Houzé S Malar J; 2016 Sep; 15(1):452. PubMed ID: 27596849 [TBL] [Abstract][Full Text] [Related]
7. Efficacy and safety of artemether-lumefantrine, artesunate-amodiaquine, and dihydroartemisinin-piperaquine for the treatment of uncomplicated Plasmodium falciparum malaria in three provinces in Angola, 2017. Davlantes E; Dimbu PR; Ferreira CM; Florinda Joao M; Pode D; Félix J; Sanhangala E; Andrade BN; Dos Santos Souza S; Talundzic E; Udhayakumar V; Owens C; Mbounga E; Wiesner L; Halsey ES; Martins JF; Fortes F; Plucinski MM Malar J; 2018 Apr; 17(1):144. PubMed ID: 29615039 [TBL] [Abstract][Full Text] [Related]
8. Artesunate-amodiaquine and artemether-lumefantrine for the treatment of uncomplicated falciparum malaria in Liberia: in vivo efficacy and frequency of molecular markers. Koko VS; Warsame M; Vonhm B; Jeuronlon MK; Menard D; Ma L; Taweh F; Tehmeh L; Nyansaiye P; Pratt OJ; Parwon S; Kamara P; Asinya M; Kollie A; Ringwald P Malar J; 2022 Apr; 21(1):134. PubMed ID: 35477399 [TBL] [Abstract][Full Text] [Related]
9. In vivo efficacy and safety of artemether-lumefantrine and amodiaquine-artesunate for uncomplicated Plasmodium falciparum malaria in Mozambique, 2018. Nhama A; Nhamússua L; Macete E; Bassat Q; Salvador C; Enosse S; Candrinho B; Carvalho E; Nhacolo A; Chidimatembue A; Saifodine A; Zulliger R; Lucchi N; Svigel SS; Moriarty LF; Halsey ES; Mayor A; Aide P Malar J; 2021 Oct; 20(1):390. PubMed ID: 34600544 [TBL] [Abstract][Full Text] [Related]
10. In vivo efficacy of artemether-lumefantrine and artesunate-amodiaquine for uncomplicated Plasmodium falciparum malaria in Malawi, 2014. Paczkowski M; Mwandama D; Marthey D; Luka M; Makuta G; Sande J; Ali D; Troell P; Mathanga DP; Gutman J Malar J; 2016 Apr; 15():236. PubMed ID: 27113085 [TBL] [Abstract][Full Text] [Related]
11. Therapeutic efficacy of artesunate-amodiaquine and artemether-lumefantrine for the treatment of uncomplicated falciparum malaria in Chad: clinical and genetic surveillance. Issa MS; Warsame M; Mahamat MHT; Saleh IDM; Boulotigam K; Djimrassengar H; Issa AH; Abdelkader O; Hassoumi M; Djimadoum M; Doderer-Lang C; Ndihiokubwayo JB; Rasmussen C; Menard D Malar J; 2023 Aug; 22(1):240. PubMed ID: 37612601 [TBL] [Abstract][Full Text] [Related]
12. Efficacy and safety of artemether + lumefantrine, artesunate + sulphamethoxypyrazine-pyrimethamine and artesunate + amodiaquine and sulphadoxine-pyrimethamine + amodiaquine in the treatment of uncomplicated falciparum malaria in Bangui, Central African Republic: a randomized trial. Djallé D; Njuimo SP; Manirakiza A; Laganier R; Le Faou A; Rogier C Malar J; 2014 Jan; 13():9. PubMed ID: 24393479 [TBL] [Abstract][Full Text] [Related]
13. Therapeutic efficacy of artesunate-amodiaquine and artemether-lumefantrine combinations for uncomplicated malaria in 10 sentinel sites across Ghana: 2015-2017. Abuaku B; Duah-Quashie NO; Quaye L; Matrevi SA; Quashie N; Gyasi A; Owusu-Antwi F; Malm K; Koram K Malar J; 2019 Jun; 18(1):206. PubMed ID: 31234874 [TBL] [Abstract][Full Text] [Related]
14. Molecular monitoring of Plasmodium falciparum drug susceptibility at the time of the introduction of artemisinin-based combination therapy in Yaoundé, Cameroon: implications for the future. Menard S; Morlais I; Tahar R; Sayang C; Mayengue PI; Iriart X; Benoit-Vical F; Lemen B; Magnaval JF; Awono-Ambene P; Basco LK; Berry A Malar J; 2012 Apr; 11():113. PubMed ID: 22498364 [TBL] [Abstract][Full Text] [Related]
15. Polymorphisms in Plasmodium falciparum chloroquine resistance transporter and multidrug resistance 1 genes: parasite risk factors that affect treatment outcomes for P. falciparum malaria after artemether-lumefantrine and artesunate-amodiaquine. Venkatesan M; Gadalla NB; Stepniewska K; Dahal P; Nsanzabana C; Moriera C; Price RN; Mårtensson A; Rosenthal PJ; Dorsey G; Sutherland CJ; Guérin P; Davis TME; Ménard D; Adam I; Ademowo G; Arze C; Baliraine FN; Berens-Riha N; Björkman A; Borrmann S; Checchi F; Desai M; Dhorda M; Djimdé AA; El-Sayed BB; Eshetu T; Eyase F; Falade C; Faucher JF; Fröberg G; Grivoyannis A; Hamour S; Houzé S; Johnson J; Kamugisha E; Kariuki S; Kiechel JR; Kironde F; Kofoed PE; LeBras J; Malmberg M; Mwai L; Ngasala B; Nosten F; Nsobya SL; Nzila A; Oguike M; Otienoburu SD; Ogutu B; Ouédraogo JB; Piola P; Rombo L; Schramm B; Somé AF; Thwing J; Ursing J; Wong RPM; Zeynudin A; Zongo I; Plowe CV; Sibley CH; Asaq Molecular Marker Study Group Am J Trop Med Hyg; 2014 Oct; 91(4):833-843. PubMed ID: 25048375 [TBL] [Abstract][Full Text] [Related]
16. Therapeutic efficacy of artemether-lumefantrine and artesunate-amodiaquine for the treatment of uncomplicated Plasmodium falciparum malaria in Mali, 2015-2016. Diarra Y; Koné O; Sangaré L; Doumbia L; Haidara DBB; Diallo M; Maiga A; Sango HA; Sidibé H; Mihigo J; Nace D; Ljolje D; Talundzic E; Udhayakumar V; Eckert E; Woodfill CJ; Moriarty LF; Lim P; Krogstad DJ; Halsey ES; Lucchi NW; Koita OA Malar J; 2021 May; 20(1):235. PubMed ID: 34034754 [TBL] [Abstract][Full Text] [Related]
17. Selection of known Plasmodium falciparum resistance-mediating polymorphisms by artemether-lumefantrine and amodiaquine-sulfadoxine-pyrimethamine but not dihydroartemisinin-piperaquine in Burkina Faso. Somé AF; Séré YY; Dokomajilar C; Zongo I; Rouamba N; Greenhouse B; Ouédraogo JB; Rosenthal PJ Antimicrob Agents Chemother; 2010 May; 54(5):1949-54. PubMed ID: 20231394 [TBL] [Abstract][Full Text] [Related]
18. Therapeutic efficacy and effects of artesunate-amodiaquine and artemether-lumefantrine on malaria-associated anaemia in Nigerian children aged two years and under. Sowunmi A; Akano K; Ayede AI; Ntadom G; Adewoye EO; Fatunmbi B; Aderoyeje T Infect Dis Poverty; 2016 Jul; 5(1):70. PubMed ID: 27384596 [TBL] [Abstract][Full Text] [Related]
19. Amodiaquine and artemether-lumefantrine select distinct alleles of the Plasmodium falciparum mdr1 gene in Tanzanian children treated for uncomplicated malaria. Humphreys GS; Merinopoulos I; Ahmed J; Whitty CJ; Mutabingwa TK; Sutherland CJ; Hallett RL Antimicrob Agents Chemother; 2007 Mar; 51(3):991-7. PubMed ID: 17194834 [TBL] [Abstract][Full Text] [Related]
20. Artemether-lumefantrine with or without single-dose primaquine and sulfadoxine-pyrimethamine plus amodiaquine with or without single-dose tafenoquine to reduce Plasmodium falciparum transmission: a phase 2, single-blind, randomised clinical trial in Ouelessebougou, Mali. Mahamar A; Smit MJ; Sanogo K; Sinaba Y; Niambele SM; Sacko A; Dicko OM; Diallo M; Maguiraga SO; Sankaré Y; Keita S; Samake S; Dembele A; Lanke K; Ter Heine R; Bradley J; Dicko Y; Traore SF; Drakeley C; Dicko A; Bousema T; Stone W Lancet Microbe; 2024 Jul; 5(7):633-644. PubMed ID: 38705163 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]